Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 43)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
9-Feb-10 New Constructs, LLC N/A TEVA: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
9-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for TEVA: the economy's impact on TEVA's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Nanotechnology & MEMS Industry Trends, Statistics & Analysis 2009 (Summary) 34 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Nanotechnology & MEMS Industry Market Research and Competitive Analysis 2009 447 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Trends, Statistics & Analysis 2010 (Summary) 98 $199 View Abstract
8-Feb-10 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract
8-Feb-10 Wall Street Transcript ,The The Wall St Transcript MONEY MANAGER INTERVIEW: Long-Term Large-Cap Investing - Glenn C. Andrews - Cardinal Capital Management 7 $50 View Abstract
6-Feb-10 Reuters Investment Profile N/A Teva Pharmaceutical Industries Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
Next 20

Brokerage Reports (Showing 1 to 10 of 11)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
27-Jan-10 Collins Stewart LLC Louise Chen Temodar Could Be Long Tailed Opportunity For PRGO and TEVA 4 $10 View Abstract
26-Jan-10 Collins Stewart LLC Louise Chen Key Takeaways From Doctor Call on Laquinimod 3 $10 View Abstract
20-Jan-10 Collins Stewart LLC Louise Chen February 2010 Catalyst Calendar 25 $75 View Abstract
15-Jan-10 Collins Stewart LLC Louise Chen Reiterating Buy and Increasing Price Target after Management Meeting 4 $10 View Abstract
12-Jan-10 Thomson StreetEvents N/A TEVA - Event Transcript of Teva Pharmaceutical conference call, Jan. 11, 2010 / 1:30pm ET 8 $75 View Abstract
11-Jan-10 Thomson StreetEvents N/A TEVA - Event Transcript of Teva Pharmaceutical conference call, Jan. 07, 2010 / 3:00pm ET 33 $75 View Abstract
8-Jan-10 Collins Stewart LLC Louise Chen Analyst Day Increases Earnings Visibility Through 2015 10 $25 View Abstract
7-Jan-10 Thomson StreetEvents N/A TEVA - Event Transcript of Teva Pharmaceutical conference call, Jan. 06, 2010 / 2:45pm ET 14 $75 View Abstract
31-Dec-09 First Global Kavita Thomas, Devina Mehra First Global reiterates Outperform on TEVA 14 $50 View Abstract
24-Dec-09 Collins Stewart LLC Louise Chen Teva-Kowa Acquisition of Majority Interest in Taisho is Good News 2 $10 View Abstract
Next 1

Independent Reports (Showing 1 to 10 of 32)

Release
Date Contributor Author Title Pages Price More Info
9-Feb-10 New Constructs, LLC N/A TEVA: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
9-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for TEVA: the economy's impact on TEVA's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Nanotechnology & MEMS Industry Trends, Statistics & Analysis 2009 (Summary) 34 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Nanotechnology & MEMS Industry Market Research and Competitive Analysis 2009 447 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Trends, Statistics & Analysis 2010 (Summary) 98 $199 View Abstract
8-Feb-10 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract
8-Feb-10 Wall Street Transcript ,The The Wall St Transcript MONEY MANAGER INTERVIEW: Long-Term Large-Cap Investing - Glenn C. Andrews - Cardinal Capital Management 7 $50 View Abstract
6-Feb-10 Reuters Investment Profile N/A Teva Pharmaceutical Industries Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.